1[1]Hermans J,Bonenkamp JJ,Boon MC,Bunt AM,Ohyama S,Sasako M,Van de Velde CJ.Adjuvant therapy after curative resection for gastric cancer:meta-analysis of randomized trials.J Clin Oncol 1993; 11:1441-1447
2[2]Earle CC,Maroun JA.Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients:revisiting a meta-analysis of randomised trials.Eur J Cancer 1999; 35:1059-64
3[3]Macdonald JS,Smalley SR,Benedetti J,Hundahl SA,Estes NC,Stemmermann GN,Haller DG,Ajani JA,Gunderson LL,Jessup JM,Martenson JA.Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.N Engl J Med 2001; 345:725-730
4[4]Greene F,Page DL,Fleming ID.Stomach.In:AJCC cancer staging manual.6th ed.New York:Springer-Verlag Publisher,2002:99-106
5[5]Oken MM,Creech RH,Tormey DC,Horton J,Davis TE,McFadden ET,Carbone PP.Toxicity and response criteria of the Eastern Cooperative Oncology Group.Am J Clin Oncol 1982; 5:649-655
6[6]Dunst J,Reese T,Sutter T,Zuhlke H,Hinke A,KollingSchlebusch K,Frings S.Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer.J Clin Oncol 2002; 20:3983-3991
7[7]Ichikura T,Tomimatsu S,Uefuji K,Kimura M,Uchida T,Morita D,Mochizuki H.Evaluation of the New American Joint Committee on Cancer/International Union against cancer classification of lymph node metastasis from gastric carcinoma in comparison with the Japanese classification.Cancer 1999; 86:553-558
10[10]Vanhoefer U,Rougier P,Wilke H,Ducreux MP,Lacave AJ,Van Cutsem E,Planker M,Santos JG,Piedbois P,Paillot B,Bodenstein H,Schmoll HJ,Bleiberg H,Nordlinger B,Couvreur ML,Baron B,Wils JA.Final results of a randomized phase Ⅲ trial of sequential high-dose methotrexate,fluorouracil,and doxorubicin versus etoposide,leucovorin,and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer:A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group.J Clin Oncol 2000; 18:2648-2657
